← Back to Analyst Consensus 
OCUL Buy
OCULAR THERAPEUTIX, INC
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 3 reiterations from 3 firms
Next Earnings
Nov 9, 2026 (13 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Oct 12, 2026 | UBS | initiate | — → Buy | — | 54% |
| Oct 2, 2026 | Chardan Capital | maintain | Buy → Buy | — | 46% |
| Sep 29, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Sep 16, 2026 | Chardan Capital | maintain | Buy → Buy | — | 46% |
| Sep 16, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 4, 2026 | Chardan Capital | maintain | Buy → Buy | — | 46% |
| Jun 25, 2026 | Chardan Capital | maintain | Buy → Buy | — | 46% |
| Jun 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 18, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| May 6, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| May 5, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Apr 13, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 3, 2026 | Clear Street | maintain | Buy → Buy | — | 48% |
| Feb 20, 2026 | Needham | maintain | Buy → Buy | $18 | 50% |
| Feb 18, 2026 | Chardan Capital | maintain | Buy → Buy | $21 | 46% |
| Dec 9, 2025 | Chardan Capital | maintain | Buy → Buy | $21 | 46% |
| Dec 8, 2025 | Needham | reiterate | Buy → Buy | $20 | 50% |
| Dec 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $21 | 44% |
| Nov 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $19 | 44% |
| Nov 5, 2025 | Chardan Capital | maintain | Buy → Buy | $21 | 46% |
| Oct 30, 2025 | TD Cowen | maintain | Buy → Buy | $20 | 54% |
| Oct 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $19 | 44% |
| Oct 3, 2025 | Piper Sandler | maintain | Overweight → Overweight | $31 | 54% |
| Oct 3, 2025 | Baird | maintain | Outperform → Outperform | $24 | 55% |
| Oct 2, 2025 | Chardan Capital | maintain | Buy → Buy | $21 | 46% |
| Oct 1, 2025 | Needham | maintain | Buy → Buy | $20 | 50% |
| Oct 1, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $29 | 53% |
| Sep 15, 2025 | Chardan Capital | initiate | — → Buy | $21 | 46% |
| Aug 6, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $20 | 55% |
| Aug 5, 2025 | Needham | maintain | Buy → Buy | $15 | 50% |
| May 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| May 6, 2025 | Needham | maintain | Buy → Buy | $14 | 50% |
| Apr 8, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| Apr 8, 2025 | Needham | reiterate | Buy → Buy | $15 | 50% |
| Mar 18, 2025 | RBC Capital | initiate | — → Outperform | $17 | 55% |
| Mar 11, 2025 | Needham | initiate | — → Buy | $15 | 50% |
| Mar 4, 2025 | Citizens Capital Markets | maintain | Market Outperform → Market Outperform | $19 | 49% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Dec 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Nov 15, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Oct 16, 2024 | Scotiabank | initiate | — → Sector Outperform | $22 | 55% |
| Oct 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Aug 8, 2024 | Baird | maintain | Outperform → Outperform | $17 | 55% |
| Aug 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Jun 21, 2024 | Piper Sandler | maintain | Overweight → Overweight | $15 | 54% |
| Jun 20, 2024 | TD Cowen | upgrade | Hold → Buy | $11 | 54% |
| Jun 14, 2024 | Piper Sandler | maintain | Overweight → Overweight | $15 | 54% |
| Jun 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| May 8, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $14 | 44% |
Price Target Trend
Jun 12, 2026 Latest: $25.45 Oct 24, 2026
EPS Estimates
0y $-1.44
Lo: $-1.54 Hi: $-1.18
5 analysts ▲3
+1y $-1.48
Lo: $-1.86 Hi: $-1.09
6 analysts ▲3
0q $-0.35
Lo: $-0.37 Hi: $-0.30
6 analysts ▲4
+1q $-0.38
Lo: $-0.43 Hi: $-0.31
6 analysts ▲4
Cross-Platform Signals
No cross-platform signals in the last 90 days